Novel Cancer Diagnostic and Therapy
The technology provides a method of assessing whether a subject is afflicted with a cancer or is at risk for developing cancer. The method compares the copy number of a minimal common region (MCR) in a subject sample to the normal copy number of the MCR. The altered copy number of the MCR indicates that the subject is afflicted with cancer or is at risk of developing cancer.
Sector: Fluid systems and components for general use
Country: India
Area of Application: Medical diagnostics
Keywords: Diagnostic, therapy, MCR
Advantages: Kit for diagnosis/prognosis of cancer Detects and determines the cancer state. Provide a compound for treating cancer. Suggest the specific therapy to the subject.
Environmental aspects: Not Applicable
Development Status: Laboratory Model
Legal Protection: Patent in Progress
Technical specifications:
Transfer Terms: Technology Licensing
Target Countries: India
Estimated cost (US$):
Upload any relevant document:
Contact Person: SkyQuest Technology Consulting Pvt. Ltd.
Address: 501, Krishna Complex, Opp. Devashish School, Bodakdev
City: Ahmedabad
Country: India
Zip/Pin Code: 380054
Contact Technology Provider
Technology offer
Interested in this technology?
Request further information or explore potential cooperation with the technology provider.
Technology request
Can you help meet this technology need?
Share a relevant technology, expertise or partnership opportunity with APCTT.